Shares of Infosys moved higher after the company announced a strategic collaboration with U.S.-based artificial intelligence firm Anthropic, reinforcing its ambitions in advanced digital and generative AI services. The market responded positively to the partnership, viewing it as a timely move that strengthens Infosys’ positioning in enterprise AI adoption. Investors interpreted the development as a long-term growth catalyst, particularly as global clients accelerate spending on automation, data intelligence and responsible AI solutions.

India’s capital markets are set to witness a landmark moment as Gaudium IVF prepares to launch the country’s first initial public offering (IPO) in the fertility services space on Feb. 20. The issue marks a significant milestone for a sector that has grown steadily on the back of rising infertility awareness, delayed parenthood and improving medical outcomes. Market participants view the offering as both a test of investor appetite for niche health care plays and a validation of fertility services as a scalable, organized business.

Indian equity benchmarks staged a measured recovery, snapping recent weakness as investors selectively accumulated frontline stocks, notably in information technology and consumer goods. Buying interest in bellwethers such as Infosys and ITC helped stabilize sentiment amid an otherwise cautious global backdrop. While broader markets remained mixed, the rebound underscored the resilience of domestic fundamentals and investors’ willingness to deploy capital into high-quality names after recent declines.

JSW MG Motor is accelerating its expansion plans in India, signaling strong confidence in the country’s long-term automotive growth story. Backed by fresh capital, new manufacturing investments and an expanding product pipeline, the company is positioning India as a strategic hub rather than a peripheral market. Industry analysts say the move reflects rising domestic demand, policy support for electric mobility and a shift in global supply chains toward Asia.

Intermittent fasting has moved from a niche wellness trend to a mainstream health discussion, drawing increasing attention from medical experts, researchers, and policymakers. Nutrition specialists say the eating pattern—defined by alternating periods of eating and fasting—shows potential benefits for weight management, metabolic health, and cardiovascular risk reduction. However, experts also caution that results vary widely depending on age, lifestyle, and existing medical conditions.

A recent study published in The Lancet has brought fresh momentum to the treatment landscape for hypertension, highlighting the promise of long-acting injectable therapies. The research suggests that periodic injections could offer sustained blood pressure control, addressing one of the biggest challenges in hypertension management—poor patient adherence to daily medication. Medical experts say the findings could mark a turning point in cardiovascular care, particularly for high-risk populations.

The National Company Law Tribunal has taken stock of the progress made on stalled real estate projects of Jaypee Infratech, a case that remains closely watched by homebuyers, lenders, and the broader insolvency ecosystem. The review focused on construction timelines, fund utilization, and compliance with commitments made under the resolution framework. While incremental progress has been reported on select projects, delays continue to test stakeholder confidence.

After years of subdued performance, Nissan is mounting a determined comeback in India, anchored by fresh product launches, sharper pricing strategies and renewed dealer confidence. The Japanese automaker is recalibrating its approach to one of the world’s most competitive car markets, betting on SUVs, localization and disciplined cost management to regain relevance. Early sales momentum suggests the strategy is beginning to resonate with Indian consumers.

Colorectal cancer is emerging as a growing public health concern among adults, with health experts noting shifts in age profiles, lifestyle factors, and diagnostic patterns. Once considered predominantly a disease of older populations, the condition is increasingly being detected in younger and middle-aged adults, raising questions about screening norms and preventive strategies. Medical professionals stress that early diagnosis dramatically improves outcomes, yet awareness remains uneven.

Global health authorities have intensified surveillance and immunization efforts following reports of new polio cases, reviving concerns about a disease once on the brink of eradication. Public health experts emphasize that the outbreak is not a failure of science but a reminder of uneven vaccine coverage and persistent gaps in healthcare access. Coordinated responses led by national governments and international agencies are now focused on rapid containment, booster campaigns, and community outreach.